Page last updated: 2024-10-25

cyclocreatine and Carcinoma, Small Cell

cyclocreatine has been researched along with Carcinoma, Small Cell in 1 studies

cyclocreatine: structure given in first source

Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)

Research Excerpts

ExcerptRelevanceReference
"Cyclocreatine was not very cytotoxic upon 24 h of exposure of human SW2 small-cell lung cancer cells to concentrations of up to 5 mM."1.29Cyclocreatine in cancer chemotherapy. ( Kaddurah-Daouk, R; Kufe, DW; Liu, J; Menon, K; Northey, D; Teicher, BA, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Teicher, BA1
Menon, K1
Northey, D1
Liu, J1
Kufe, DW1
Kaddurah-Daouk, R1

Other Studies

1 other study available for cyclocreatine and Carcinoma, Small Cell

ArticleYear
Cyclocreatine in cancer chemotherapy.
    Cancer chemotherapy and pharmacology, 1995, Volume: 35, Issue:5

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Small Cell; Carmustine; Cell Division; Ce

1995